132 related articles for article (PubMed ID: 37752647)
1. [DNA Methylation Profile of CD14+ Monocytes Changes in Primary Progressive Multiple Sclerosis].
Kiselev IS; Kulakova OG; Baturina OA; Kabilov MR; Boyko AN; Favorova OO
Mol Biol (Mosk); 2023; 57(5):819-826. PubMed ID: 37752647
[TBL] [Abstract][Full Text] [Related]
2. [Genome-Wide Analysis of DNA Methylation in Cd4+ T Lymphocytes of Patients with Primary Progressive Multiple Sclerosis Indicates Involvement of This Epigenetic Process in the Disease Immunopathogenesis].
Kiselev IS; Kulakova OG; Danilova LV; Baturina OA; Kabilov MR; Popova EV; Boyko AN; Favorova OO
Mol Biol (Mosk); 2022; 56(3):468-475. PubMed ID: 35621102
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide DNA methylation profiling identifies epigenetic changes in CD4+ and CD14+ cells of multiple sclerosis patients.
Kiselev I; Danilova L; Baulina N; Baturina O; Kabilov M; Boyko A; Kulakova O; Favorova O
Mult Scler Relat Disord; 2022 Apr; 60():103714. PubMed ID: 35245816
[TBL] [Abstract][Full Text] [Related]
4. Whole-Genome DNA Methylation Analysis of Peripheral Blood Mononuclear Cells in Multiple Sclerosis Patients with Different Disease Courses.
Kulakova OG; Kabilov MR; Danilova LV; Popova EV; Baturina OA; Tsareva EY; Baulina NM; Kiselev IS; Boyko AN; Favorov AV; Favorova OO; Vlassov VV
Acta Naturae; 2016; 8(3):103-110. PubMed ID: 27795849
[TBL] [Abstract][Full Text] [Related]
5. Combining evidence from four immune cell types identifies DNA methylation patterns that implicate functionally distinct pathways during Multiple Sclerosis progression.
Ewing E; Kular L; Fernandes SJ; Karathanasis N; Lagani V; Ruhrmann S; Tsamardinos I; Tegner J; Piehl F; Gomez-Cabrero D; Jagodic M
EBioMedicine; 2019 May; 43():411-423. PubMed ID: 31053557
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic aspects of multiple sclerosis and future therapeutic options.
Jamebozorgi K; Rostami D; Pormasoumi H; Taghizadeh E; Barreto GE; Sahebkar A
Int J Neurosci; 2021 Jan; 131(1):56-64. PubMed ID: 32075477
[TBL] [Abstract][Full Text] [Related]
7. Genetic differences between primary progressive and relapsing-remitting multiple sclerosis: The impact of immune-related genes variability.
Kiselev I; Bashinskaya V; Baulina N; Kozin M; Popova E; Boyko A; Favorova O; Kulakova O
Mult Scler Relat Disord; 2019 Apr; 29():130-136. PubMed ID: 30711878
[TBL] [Abstract][Full Text] [Related]
8. Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis.
Ratzer R; Søndergaard HB; Christensen JR; Börnsen L; Borup R; Sørensen PS; Sellebjerg F
Mult Scler; 2013 Dec; 19(14):1841-8. PubMed ID: 24085340
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of MIR21 in CD4+ T cells from patients with relapsing-remitting multiple sclerosis associates with lower miRNA-21 levels and concomitant up-regulation of its target genes.
Ruhrmann S; Ewing E; Piket E; Kular L; Cetrulo Lorenzi JC; Fernandes SJ; Morikawa H; Aeinehband S; Sayols-Baixeras S; Aslibekyan S; Absher DM; Arnett DK; Tegner J; Gomez-Cabrero D; Piehl F; Jagodic M
Mult Scler; 2018 Sep; 24(10):1288-1300. PubMed ID: 28766461
[TBL] [Abstract][Full Text] [Related]
10. Global transcriptome profiling of mild relapsing-remitting versus primary progressive multiple sclerosis.
Koch MW; Ilnytskyy Y; Golubov A; Metz LM; Yong VW; Kovalchuk O
Eur J Neurol; 2018 Apr; 25(4):651-658. PubMed ID: 29316044
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide DNA methylation changes in CD19
Maltby VE; Lea RA; Graves MC; Sanders KA; Benton MC; Tajouri L; Scott RJ; Lechner-Scott J
Sci Rep; 2018 Nov; 8(1):17418. PubMed ID: 30479356
[TBL] [Abstract][Full Text] [Related]
12. Trans-omics analyses revealed key epigenetic genes associated with overall survival in secondary progressive multiple sclerosis.
Ye F; Dai Y; Wang T; Liang J; Wu X; Lan K; Sheng W
J Neuroimmunol; 2022 Mar; 364():577809. PubMed ID: 35026432
[TBL] [Abstract][Full Text] [Related]
13. [A comparison of DNA methylation profiles of blood mononuclear cells in patients with multiple sclerosis in remission and relapse].
Kiselev IS; Kulakova OG; Baturina OA; Kabilov MR; Boyko AN; Favorova OO
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(7. Vyp. 2):60-64. PubMed ID: 37560835
[TBL] [Abstract][Full Text] [Related]
14. Differential methylation at
Maltby VE; Lea RA; Sanders KA; White N; Benton MC; Scott RJ; Lechner-Scott J
Clin Epigenetics; 2017; 9():71. PubMed ID: 28729889
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic differences at the HTR2A locus in progressive multiple sclerosis patients.
Maltby VE; Lea RA; Burnard S; Xavier A; Van Cao T; White N; Kennedy D; Groen K; Sanders KA; Seeto R; Bray S; Gresle M; Laverick L; Butzkueven H; Scott RJ; Lechner-Scott J
Sci Rep; 2020 Dec; 10(1):22217. PubMed ID: 33335118
[TBL] [Abstract][Full Text] [Related]
16. The familial risk and heritability of multiple sclerosis and its onset phenotypes: A case-control study.
Boles GS; Hillert J; Ramanujam R; Westerlind H; Olsson T; Kockum I; Manouchehrinia A
Mult Scler; 2023 Sep; 29(10):1209-1215. PubMed ID: 37435869
[TBL] [Abstract][Full Text] [Related]
17. CXCL10 and CXCL13 chemokines in patients with relapsing remitting and primary progressive multiple sclerosis.
Iwanowski P; Losy J; Kramer L; Wójcicka M; Kaufman E
J Neurol Sci; 2017 Sep; 380():22-26. PubMed ID: 28870573
[TBL] [Abstract][Full Text] [Related]
18. Genome-Wide DNA Methylation and Gene Expression in Patients with Indolent Systemic Mastocytosis.
Górska A; Urbanowicz M; Grochowalski Ł; Seweryn M; Sobalska-Kwapis M; Wojdacz T; Lange M; Gruchała-Niedoszytko M; Jarczak J; Strapagiel D; Górska-Ponikowska M; Pelikant-Małecka I; Kalinowski L; Nedoszytko B; Gutowska-Owsiak D; Niedoszytko M
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762215
[TBL] [Abstract][Full Text] [Related]
19. SIGLEC1 and SIGLEC7 expression in circulating monocytes of patients with multiple sclerosis.
Malhotra S; Castilló J; Bustamante M; Vidal-Jordana A; Castro Z; Montalban X; Comabella M
Mult Scler; 2013 Apr; 19(5):524-31. PubMed ID: 22933622
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic changes in patients with multiple sclerosis.
Koch MW; Metz LM; Kovalchuk O
Nat Rev Neurol; 2013 Jan; 9(1):35-43. PubMed ID: 23165337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
